Literature DB >> 7710536

Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis?

P Gottfarb1, A Brauner.   

Abstract

52 children with severe cough persisting for more than 10 days were randomized to treatment with amoxycillin/clavulanic acid or placebo in a prospective double-blinded study. Clinically suspected cases of pertussis were excluded, yet 12 (23%) of the children had laboratory verified pertussis infection. The nasopharyngeal colonization showed a predominance of Moraxella catarrhalis which was isolated in 37 (71%) children. Streptococcus pneumoniae and Haemophilus influenzae were isolated in 11 (20%) and 16 (30%) children, respectively. The antibiotic-treated group had a significantly better recovery in both the pediatrician's estimation (p = 0.02) and the independent parental judgement (p = 0.002). These findings are consistent with the view that Moraxella catarrhalis could be directly involved in the pathogenesis of persistent cough in children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7710536     DOI: 10.3109/00365549409011812

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  17 in total

1.  In children with prolonged cough, does treatment with antibiotics have a better effect on cough resolution than no treatment?: Part A: Evidence-based answer and summary.

Authors:  Emily J Bailey; Ab Chang
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

2.  Systematic review of the treatment of upper respiratory tract infection.

Authors:  T Fahey; N Stocks; T Thomas
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 3.  Antibiotics for acute bronchitis.

Authors:  Susan M Smith; Tom Fahey; John Smucny; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2017-06-19

Review 4.  Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication.

Authors:  Malcolm Gillies; Anggi Ranakusuma; Tammy Hoffmann; Sarah Thorning; Treasure McGuire; Paul Glasziou; Christopher Del Mar
Journal:  CMAJ       Date:  2014-11-17       Impact factor: 8.262

5.  Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.

Authors:  W G Hu; J Chen; J F Battey; X X Gu
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children.

Authors:  D Chen; V Barniak; K R VanDerMeid; J C McMichael
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope.

Authors:  J C McMichael; M J Fiske; R A Fredenburg; D N Chakravarti; K R VanDerMeid; V Barniak; J Caplan; E Bortell; S Baker; R Arumugham; D Chen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 8.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

9.  Colonization and infection with Moraxella catarrhalis in childhood.

Authors:  R Berner; R F Schumacher; M Brandis; J Forster
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 10.  Antibiotics for the common cold and acute purulent rhinitis.

Authors:  Tim Kenealy; Bruce Arroll
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.